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ABSTRACT: The paramagnetic spin relaxation (PSR) filter allows the suppression of the NMR resonances of individual components in 
mixtures according to their Gd3+-complexing ability. The difficulty in predicting this property hampers, however, the widespread application 
of this filter. Herein we describe that the PSR filter is dominated by the transverse relaxation enhancement (R2p) experienced by nuclei in the 
presence of Gd3+ and so, that R2p represents a reliable predictive tool of suppression in the 1D and 2D PSR filter of complex mixtures. The 
robustness of R2p as a predictive tool in PSR filters has been demonstrated at different magnetic fields and for the 1H, 13C, COSY and HMQC 
filtering of commercial multicomponent compositions, including beverages and drugs. 
INTRODUCTION 
Recent advances in pulse sequences and NMR allow the analysis of 
individual components in complex mixtures by implementing filters 
that avoid the necessity of previous separations.1 Widely used filters 
rely on differences in the relaxation times and diffusion coefficients of 
the components. As small molecules generally display larger relaxation 
times and shorter diffusion coefficients than high molecular weight 
species, these filters complement each other allowing the selective 
suppression of one of these two large groups of components in mix-
tures. The hurdle arises when selectivity within these groups is desired. 
It is therefore of much interest the development of filtering strategies 
that based on alternative properties could expand the limits of tradi-
tional filters. 
Our research group has recently described the use of Gd3+ as a par-
amagnetic spin relaxation (PSR) agent for the selective suppression of 
the 1H and 13C resonances of Gd3+-complexing components in mix-
tures (1D and 2D NMR).2 The PSR filter relies on the faster relaxation 
of nuclei in a paramagnetic environment.3 Gd3+ has seven unpaired 
electrons and a high electronic correlation time (s ca 10-8 s), which 
being larger than the rotational correlation time (r) of small molecules 
and most macromolecules, affords overall correlation times (c) domi-
nated by r. In this scenario, the Solomon-Bloembergen-Morgan equa-
tions predict a dramatic reduction of the transverse relaxation time 
(T2) for those species in fast chemical exchange with Gd3+.4 Because of 
the inverse proportionality between T2 and the spectral line width in 
NMR spectra,5 this ultimately results in their selective line-
broadening/suppression without affecting the resolution and chemical 
shift of other components in a mixture.2,6 
The PSR filter benefits from a rather low sensitivity to size and mo-
lecular weight that makes it compatible with classical relaxation and 
diffusion filters. A limitation that might hamper its wide adoption by 
the community is a reduced predictive character, mainly restricted to 
anionic species being generally easier to filter than neutral/cationic 
ones. In our effort to grant PSR with a predictive tool we have turned 
our attention to the transverse relaxation enhancements (R2p) experi-
enced by nuclei in the presence of Gd3+. The transverse relaxation rate 
of nuclear spins in a paramagnetic environment (R2=1/T2) is given by 
R2=R2d+c·R2p   (1) 
where R2d is the transverse relaxation rate in the absence of paramag-
netic effects (R2d=1/T2d) and c the concentration of the paramagnetic 
species.7 Bearing in mind that T2d values for common molecules and 
polymers usually lay in a short 0.1-3 s range, it was hypothesized that 
successful PSR suppressions must rely on large R2p values more than on 
the original R2d. With the aim of assessing R2p as a predictive tool in 
PSR, the R2p values of a series of more than forty small molecules and 
polymers of interest in the pharmaceutical and food industries have 
been determined in the presence of Gd3+, and the outcome of the PSR 
filter in relevant compositions in these fields analysed in the light of the 
R2p of the constituents. As a result, three large groups of molecules and 
polymers have been disclosed that according to their R2p can be pre-
dictably filtered in complex mixtures by the simple addition of Gd3+, 
alone or in combination with T2 filters; confirming R2p as a convenient 
predictive tool of selectivity in PSR filters. 
 
EXPERIMENTAL SECTION 
Materials. Gd2(SO4)3∙8H2O was purchased from Aldrich. Chi-
tosan·HCl was obtained from FMC BioPolymer (Mw 80000 by SEC-
MALLS, degree of acetylation 14% by 1H NMR). Dextran from Leuco-
nostoc mesenteroides (Mn 33698, Mw 65794, by GPC), mannan from 
Saccharomyces cerevisiae (Mn 34000, Mw 36000, by SECMALLS), citric 
acid, glucuronic acid, lactose, poly-L-lysine hydrobromide (PLL) (Mn 
12400, Mw 16100, by LALLS), poly(methacrylic acid) sodium salt 
(PMAA) (Mw 29600 by GPC), myo-inositol, D-galacturonic acid 
monohydrate, codeine, sodium cyclamate, and paracetamol were pur-
chased from Fluka. Methyl α-D-glucopyranoside, sucrose, acetylsalicyl-
ic acid, sodium ascorbate, taurine, saccharin, lidocaine, warfarin, D-
glucosamine hydrochloride, -glycerol phosphate disodium salt pen-
tahydrate, chondroitin sulfate sodium salt (Mn 66784, Mw 114098, by 
GPC), and polyacrylamide (PAM) (Mw 5200000) were obtained from 
Sigma. Isomannide, L-isoleucine, 3-methoxypropionic acid, and poly-
 
 
acrylic acid (PAA) samples: PAA 450000 (Mv 450000) and PAA 1800 
(Mn 1022, Mw 1773) were purchased from Aldrich. Caffeine, D-
mannitol, acetylcysteine, and sulfated -cyclodextrin were purchased 
from Sigma-Aldrich. Polyvinylpyrrolidone (PVP) samples were ob-
tained from Fluka (Mw 360000), Sigma (Mw 10000), and Aldrich (Mw 
55000). PVP 10000 was purified by precipitation from MeOH-Et2O 
before NMR experiments. Poly(ethylene glycol) (PEG) was purchased 
from Sigma (Mp 12703, Mw 10732, by GPC). Hyaluronic acid (Mw 
160000) was obtained from Aldrich. Polyvinyl alcohol (PVA) (Mw 
60000 by GPC) was obtained from Acros. Fructose was obtained from 
Azaconsa. Arixtra® (fondaparinux sodium) was kindly provided by 
GlaxoSmithKline. Flumil Forte® 600 mg was obtained from Phar-
mazam. Cafiaspirina® was obtained from Bayer. Acetylcysteine Mylan® 
600 mg was obtained from Mylan Pharmaceuticals. 
Each Flumil Forte® effervescent tablet contains 600 mg of acetylcys-
teine and citric acid as NMR visible excipient. Each Cafiaspirina® tablet 
contains 500 mg of acetylsalicylic acid and 50 mg of caffeine. Each 
Acetylcysteine Mylan® granules for oral solution contains 600 mg of 
acetylcysteine along with mannitol, citric acid, and sodium saccharin as 
NMR visible excipients. 
Determination of molecular weight of polymers. Gel permeation 
chromatography (GPC) for chondroitin sulfate and PVA was per-
formed on a Malvern Viscotek TDA 305 with refractometer, right 
angle light scattering and viscometer detectors. Samples were meas-
ured with a Suprema precolumn (5 m, 8 x 50 mm), Suprema 30 Å (5 
m, 8 x 300 mm), Suprema 1000 Å (5 m, 8 x 300 mm), and 
PLaquagel-OH-Mixed (8 m, 7.5 x 300 mm) columns. The system 
was kept at 30 oC. 0.1 M NaN3, 0.01 M NaH2PO4, pH 7.5 was used as 
eluent at a rate of 1 mL/min. Pullulan 200 kDa (PSS standard services) 
was used to calibrate the laser detector and a set of ten pullulan samples 
(180 Da to 355 kDa) was used to obtain the molecular weight based on 
retention time. 
The molecular weight of chitosan and mannan was determined by 
SEC-MALLS. An Iso Pump G1310A (Hewlett-Packard) was connect-
ed to two PSS Novema GPC columns (10 μm, 30 Å, 8 × 300 mm; and 
10 μm, 3000 Å, 8 × 300 mm). A PSS SLD7000 MALLS detector 
(Brookhaven Instruments Corporation) operating at 660 nm and a 
G1362A refractive index detector (Agilent) were connected on line. A 
0.15 M NH4OAc/0.2 M AcOH buffer (pH 4.5) was used as eluent. 
Polymer solutions were filtered through 0.2 μm pore size membranes 
before injection. 
Determination of transverse relaxation enhancement (R2p) val-
ues. 1H R2p values in Tables 1 and S1 were determined at 8 mg/mL in 
D2O (500 MHz). To this end, transverse relaxation times were meas-
ured in the absence (T2d=1/R2d) and the presence (T2=1/R2) of 13 M 
Gd3+. In those species that at 13 M Gd3+ revealed T2d<150 ms and 
differences between T2d and T2 lower than 10% (in the range of the 
experimental error), reported R2p values were obtained at 1 mM Gd3+ 
(dextran, PVA, PVP, chitosan, PLL). R2p of warfarin was determined in 
3% D2O/DMSO-d6. R2p values in Tables 1 and S1 are weighted arith-
metic mean values of all 1H resonances in the sample. Maximum and 
minimum T2 (T2max, T2min) and T2d (T2dmax, T2dmin) values for all species 
are shown in Table S1. 
Transverse relaxation (T2) values were determined using the Carr-
Purcell-Meiboom-Gill (CPMG) pulse sequence using 16 values of 
spin-echo time (τ), with a minimum of 1.4 ms and a maximum of about 
6 to 7 times the highest T2. The delay between 180º pulses in the 
CPMG block was 1.4 ms and the number of scans was set at 32. The 
absolute signal integral or signal intensity (I) at each value of  was 
fitted to the following equation: 
I()/I0=exp(-/T2)   (2) 
where I() and I0 are the observed signal integrals or intensities at a 
given value of  and for  equal to 0, respectively. 
Sample preparation. A tablet of Cafiaspirina® was grinded and sus-
pended in D2O (1.5 mL). After stirring overnight it was filtered and 
lyophilized. The resulting white solid was dissolved in D2O at the indi-
cated concentration. Flumil Forte® and Acetylcysteine Mylan® were 
directly dissolved in D2O. Arixtra® (fondaparinux sodium) provided as 
a powder was dissolved in D2O at the indicated concentration. Mix-
tures were usually prepared in the range 1-20 mg/mL with relative 
concentrations between the components to ensure a comparable in-
tensity of their signals in the NMR spectra. 
 
RESULTS AND DISCUSSION 
The transverse relaxation enhancement (R2p) as a predictive 
tool for PSR filters. To evaluate the utility of R2p as a predictive tool in 
PSR filters, various sugars, alkaloids, drugs, artificial sweeteners and 
food additives, aminoacids, vitamins, polyaminoacids, polysaccharides 
and synthetic polymers were selected and their R2p determined (Table 
1 and SI). Not unexpectedly, larger R2p values arise in general for ani-
onic species (polymeric and low molecular weight carboxylates, sul-
fates and phosphates) in agreement with their higher Gd3+-complexing 
ability; followed by lower R2p for neutral and cationic species. In out-
line, Table 1 justifies the successful PSR filters described in our previ-
ous report based on an empirical basis.2 The large differences in R2p 
between polyacrylic acid (PAA)/hyaluronic acid (HA)/citric acid on 
one side and lactose/dextran/polyvinylpyrrolidone (PVP)/methyl--
D-glucoyranoside/caffeine on the other side might be used to explain 
the 1H and 13C PSR filtering of the former species in the NMR of their 
mixtures. In another example, the combined use of PSR and T2-filters 
allowed the sequential suppression of the components in a ternary HA-
mannan-PVP1000 mixture according to their R2p. However, moving R2p 
from a posteriori justification to a predictive tool of selectivity in PSR 
requires from a correct interpretation of Table 1. In other words, are 
successful PSR suppressions dictated by a minimum difference in R2p? 
Or, is the relative position of the species in Table 1 the critical factor 
controlling efficiency? In addition, the low R2p displayed by species like 
cyclamate, taurine or saccharin complicates the interpretation of PSR 
filters only on the basis of the anionic character of the species. With the 
objective of answering these questions, the efficiency of the PSR filter 
was analysed in mixtures of relevance in the pharmaceutical and food 
industry that comprise species covering the whole range of R2p values 
in Table 1, namely: a dermal filler composed of HA and lidocaine as 
local anesthetic, a mixture of the commercial anticoagulants Arixtra® 
and warfarin, the beverage Red Bull® (taurine, sucrose, glucose, citric 
acid), the drugs Flumil Forte® (acetylcysteine and citric acid), Cafi-
aspirine® (acetylsalicylic acid and caffeine) and Acetylcysteine Mylan® 
(acetylcysteine, citric acid, sodium saccharin), and the artificial sweet-












TABLE 1. R2p (s-1mM-1) values in D2O (8 mg/mL, 13 M Gd3+, 
500 MHz). 
 
PAA [polyacrylic acid], HA [hyaluronic acid], PAM [polyacryla-
mide], PMAA [poly(methacrylic acid)], PEG [poly(ethylene glycol)], 
PVA [poly(vinyl alcohol)], PVP [polyvinylpyrrolidone], PLL [poly-L-
lysine]. 
 
The PSR filter in mixtures with large difference in R2p: a dermal 
filler, an anticoagulant composition and Red Bull®. We started 
analysing the selectivity of the PSR filter in two mixtures with compo-
nents displaying quite different R2p values such as, hyaluronic acid 
(HA)-lidocaine (R2p 3039 vs 15) and Arixtra®-warfarin (R2p 2939 vs 
12). Dermal fillers based on HA are the most widely used injectables to 
augment facial volume. Commercial formulations including lidocaine 
as local anesthetic have been approved by the FDA.8 Aristra® is the 
commercial trademark for the anticoagulant fondaparinux, a synthetic 
sulfated pentasaccharide derived from heparin that inhibits Factor Xa. 
The combined use of Aristra® with warfarin is indicated for the treat-
ment of acute venous thromboembolism.9 Based on the large differ-
ence in R2p between the constituents in the mixtures, selective PSR 
suppressions were anticipated for fondaparinux and HA, the species 
with largest R2pvalues. Figures 1 and S1 show that the simple addition 
of minute concentrations of Gd3+ to both mixtures resulted indeed in 
their selective filtering, confirming the predictive character of R2p and 
the efficiency of the PSR filter in the analysis of complex mixtures. 
 
 
Figure 1. 1H NMR spectra (D2O, 500 MHz, 300 K) of a mixture of 
Arixtra® (4.8 mg/mL) and warfarin (1.1 mg/mL) before (a) and after 
(b) the addition of Gd3+ (30 M). 
 
Similar selectivity was achieved in the PSR filter of Red Bull®. Figure 
2 shows NMR spectra of Red Bull® where the characteristic signals of 
the major constituents are easily identified: citrate (R2p 773), taurine 
(R2p 23), sucrose and glucose (R2p<10). Because of the R2p values of 
the constituents, the selective suppression of citrate was expected. Red 
Bull® represents, however, a more challenging mixture than the above 
examples. Citric acid displays a lower R2p than HA and Arixtra®. This 
along with the more alike molecular weight of the constituents and the 
presence of a rather Gd3+-complexing sulfate in taurine might result in 
extra hurdles for the suppression. Gratifyingly, the addition of Gd3+ to 
Red Bull® resulted in the very selective suppression of only the signals 
of citric acid in the 1H NMR spectrum of the mixture. Identical selec-
tivity was also revealed in COSY, HMQC, and even 13C spectra (Figure 
2), supporting the validity of 1H R2p data in the prediction of PSR filters 













Figure 2. 13C, 1H-1H COSY, and 1H-13C HMQC NMR spectra (D2O, 
500 MHz 1H, 125 MHz 13C, 300 K) of lyophilized Red Bull® (160 
mg/mL) before (a, c, e) and after (b, d, f) the addition of Gd3+ (0.5 
mM). CA=citric acid, T=taurine, S=sugars. 
The PSR filter in compositions with reduced R2p difference be-
tween the components: Flumil Forte® and Cafiaspirina®. With the 
aim of further evaluating the potential of R2p in the prediction of selec-
tive PSR filters, we proceeded to analyse two commercial drugs having 
components with close R2p values: Flumil Forte® and Cafiaspirina®. 
Flumil Forte® is a mucolytic drug composed of the active ingredient 
acetylcysteine (R2p 101) and citric acid (R2p 773) as the only 
NMR-visible components. Cafiaspirina® is a widely used analgesic for 
the treatment of a variety of aches and pains. It combines acetylsalicylic 
acid (R2p 124) with caffeine (R2p 1). Our aim was to develop conditions 
for selectively filtering the species with largest R2p (citric acid, acetylsal-
icylic acid) while leaving unaffected the other main components (ace-
tylcysteine, caffeine). 
In Flumil Forte®, the higher R2p of acetylcysteine compared to 
PSR-inactive species seen in the previous section, like lido-
caine/warfarin/taurine/sucrose, prevented the selective PSR filtering 
of citric acid in the 1H NMR spectrum without affecting the resolution 
of acetylcysteine. Still, a clean suppression was possible at low Gd3+ 
concentrations when PSR was combined with a short T2-filter (Figure 
3). T2-filters such as the Carr−Purcell−Meiboom−Gill (CPMG) and 
related sequences keep the magnetization (I) in the transverse plane 
before acquisition, allowing the magnetization of different nuclei to 
decay according to their T2 values (the shorter the T2, the faster the 
decay, eq 2).10 Eventually, after a certain time (t), differences in T2 can 
be exploited for the selective suppression of the signals of lower T2. 
I = I0·exp(-t/T2)     (2) 
Figure 3 shows the normalized 1H signal intensities (I/I0) of citric 
acid and acetylcysteine in Flumil Forte® as a function of time before 
and after the addition of 20 M Gd3+; a concentration low enough to 
selectively induce a huge relaxation effect to citric acid while leaving 
practically unaffected the relaxation and resolution of acetylcysteine. 
These conditions do not account for the direct and complete suppres-
sion of citric acid, but this can be easily achieved by complementing the 
addition of Gd3+ with a very short 25 ms CPMG filter (Figure 3). 
The relatively small dependence of T2 on the magnetic field11 en-
couraged us to test the robustness of this combined PSR-CPMG strat-
egy at different fields. To this end, the PSR conditions developed at 
500 MHz (20 M Gd3+/25 ms CPMG) were successfully implement-
ed in spectrometers operating at 300 and 750 MHz, demonstrating the 
utility of the tool at fields different to that used in the determination of 
R2p (Figure 3). The fidelity of PSR-CPMG was also demonstrated in 
2D experiments where the CPMG sequence was used as an excitation 
block replacing the first excitation pulse.12 This way, filtered COSY and 
HMQC spectra of Flumil Forte® were easily obtained by application of 
the same 20 M Gd3+/25 ms CPMG conditions to afford spectra 
showing only the signals of acetylcysteine. Alternatively, more straight-
forward conditions to filtered COSY, HMQC and even 13C spectra 
were developed in the absence of the CPMG block by increasing the 
concentration of Gd3+ up to 0.2 mM, exploiting the lower signal resolu-
tion of 2D and 13C experiments compared to 1H (Figure S2). 
 
Figure 3. 1H NMR spectra (D2O, 300 K) of Flumil Forte® (20 
mg/mL) before (a, 500 MHz) and after (b, 500 MHz; c, 750 MHz; d, 
300 MHz) the addition of Gd3+ (20 M) + T2 filter (CPMG, 25 ms). 
Normalized 1H intensities (I/I0, 500 MHz) of citric acid (methylene 
protons) and acetylcysteine (acetyl group) in the mixture before and 
after the addition of Gd3+. 
 
 
As for Cafiaspirina®, the smaller difference in R2p between acetylsali-
cylic acid and caffeine (ca 100 s-1mM-1) anticipated the suppression of 
the former as a difficult task. Indeed, the direct PSR filter turned unfea-
sible by the simple addition of Gd3+ (Figure 4). Only the acetyl group 
and H6 of acetylsalicylic acid, the nuclei in closer proximity to the 
complexing carboxylate, could be completely removed from the 1H 
NMR spectrum of the mixture. The viability of a combined PSR-
CPMG strategy was then evaluated. Figure 4 shows the normalized 1H 
signal intensities (I/I0) of acetylsalicylic acid and caffeine in Cafiaspiri-
na® as a function of time before and after the addition of 1 mM Gd3+. As 
in the previous example, the higher R2p of acetylsalicylic acid compared 
to caffeine translates into a much faster relaxation in the presence of 
Gd3+, which can be exploited in a selective suppression when combined 
with a 200 ms CPMG filter (Figure 4). Here again, the selectivity of the 
PSR-CPMG filter was further extended to COSY and HMQC, allow-
ing the selective visualization of only the caffeine signals by using the 
same conditions as the 1H spectrum. As for the magnetic field, the 
application of the filtering conditions developed at 500 MHz to spec-
trometers operating at 300 and 750 MHz also proceeded with com-
plete selectivity (Figure S3). 
 
Selectivity in PSR filters is dominated by R2p rather than the 
original T2d values. The experiments shown above confirm R2p as a 
useful tool for the reliable prediction of selective PSR filters. An analy-
sis of these suppressions in the light of the R2p values in Table 1 sug-
gests that the difference in R2p among the components in a mixture 
might not be the key factor controlling the feasibility of a filter com-
pared to their relative position in the table. Thus, species at the top of 
Table 1 can be selectively filtered in the presence of others at the bot-
tom by the simply addition of Gd3+, while the combined use of Gd3+ 
and T2-filters of different length is required for selective suppressions 
among species at the top-medium and medium-bottom parts. These 
characteristic behaviours led us to propose three groups of compounds 
in Table 1 according to their ease of suppression by PSR, namely blue 
(B), yellow (Y), and red (R) at the upper, medium, and bottom parts, 
respectively. By studying the selectivity of PSR filters in two-
component mixtures of species selected all along Table 1, not only the 
existence of the BYR groups was verified and their borders identified, 
but general suppression conditions among them unveiled (see below). 
Table 2 depicts successful and failed suppressions within these pairs, 
while NMR spectra and particular filtering conditions are included in 
Figures S4-S14. 
 B-R: Easiest suppressions to accomplish. Concentrations of 
Gd3+<0.4 mM for 1H, COSY and HMQC, and larger concentra-
tions for 13C (smaller gyromagnetic ratio of 13C than 1H). 
 B-Y: Same conditions as B-R complemented with CPMG filters 
up to 25 ms for 1H, COSY and HMQC. 13C filters are feasible 
without CPMG by increasing the concentration of Gd3+ (also of 
application for COSY and HMQC). 
 Y-R: 0.4-2.0 mM Gd3+ complemented with 25-300 ms CPMG 
for 1H, COSY and HMQC. 
As an example to illustrate that selectivity in PSR is dominated by 
R2p rather than the original T2d values (T2d in Table S1), an unfeasible 
filter in terms of T2d was considered to involve acetylsalicylic acid, the Y 
species with largest T2d (T2d=3.4 s; R2p 124), and dextran, a R compo-
nent among those with lowest T2d (T2d<0.1 s; R2p 31). For a successful 
PSR filter in such a mixture, a selective relaxation enhancement on 
acetylsalicylic acid is required in order to afford final T2 values below 
those of dextran. Figure 5 shows the dependence of the T2 of both 
species on the concentration of Gd3+. Clearly, 0.2 mM Gd3+ represents 
a threshold from which T2 values of acetylsalicylic acid become lower 
than dextran. Increasing the concentration of Gd3+ up to 1.8 mM re-
sulted in even larger differences in T2 that could be exploited for the 




Figure 4. 1H, 1H-1H COSY, and 1H-13C HMQC spectra (D2O, 500 
MHz, 300 K) of Cafiaspirina® (4 mg/mL) before (a, d, f) and after (b) 
the addition of Gd3+ (1 mM), and after the addition of Gd3+ (1 mM) + 
T2 filter (CPMG, 200 ms) (c, e, g). Normalized 1H intensities (I/I0) of 
acetylsalicylic acid (H5) and caffeine (aromatic H) in the mixture 




TABLE 2. Successful and failed PSR suppressions in two-component mixtures (D2O, 500 MHz). 
 




Figure 5. Right panel: 1H NMR spectra (D2O, 500 MHz, 300 K) of a 
mixture of dextran (1 mg/mL) and acetylsalicylic acid (1 mg/mL) 
before (a) and after (b) the addition of Gd3+ (1.8 mM) + T2 filter 
(CPMG, 20 ms). Left panel: Dependence of 1H T2 of dextran and 
acetylsalicylic acid on the concentration of Gd3+. 
 
R2p in the prediction of selective PSR filters in multicomponent 
mixtures. Having stablished the utility of R2p and the BYR groups in 
the prediction of PSR filters in two-component mixtures, we decided to 
test their potential in more complex systems. With this aim the drug 
Acetilcisteina Mylan® and the artificial sweetener Natreen® were select-
ed as multicomponent preparations. Acetilcisteina Mylan® is a com-
mercial mucolytic drug related to Flumil Forte®, which in addition to 
acetylcysteine (R2p 101) and citric acid (R2p 773), incorporates D-
mannitol (R2p 87) and sodium saccharin (R2p 23). According to the 
position of each component in Table 1, our objective was to selectively 
filter citric acid (B component) in a first PSR-CPMG, followed by 
acetylcysteine and mannitol (Y components) in a second step. As seen 
in Figure 6, by using concentrations of Gd3+ and CPMG lengths within 
the limits indicated in Table 2, the two sequential PSR-CPMG filters 
proceeded as expected with complete selectivity. Gratifyingly, this 
two-step filtering strategy also revealed successful when analysing a 
mixture of the three components of Natreen® [citric acid (R2p 773, B 
component), sodium cyclamate (R2p 78, Y component), sodium sac-
charin (R2p 23, R component)], confirming the utility of R2p as a valua-




Figure 6. 1H NMR spectra (D2O, 500 MHz, 300 K) of Acetilcisteina 
Mylan® (25 mg/mL) supplemented with saccharin (12.5 mg/mL) 
before (a) and after the addition of (b) Gd3+ (20 M) + 25 ms CPMG, 





The paramagnetic spin relaxation (PSR) filter has been recently de-
scribed by our laboratory as a tool for the NMR suppression of the 1H 
and 13C resonances of individual components in mixtures according to 
their Gd3+-complexing ability. It is based on the faster relaxation of 
nuclei in a paramagnetic environment and so, complements traditional 
filters like relaxation and diffusion filters. Herein we describe that the 
PSR filter is dominated by the transverse relaxation enhancement (R2p) 
of the nuclei rather than the original T2d values and so, that R2p repre-
sents a reliable predictive tool of selectivity in the PSR filter of complex 
mixtures. The analysis of the R2p of a series of small molecules and 
polymers of interest in the pharmaceutical and food industry (Table 
1), along with the conditions of the PSR filter in various of their com-
mercial mixtures, has led us to identify three large groups of com-
pounds in Table 1 according to their ease of suppression by PSR (R2p 
value) in 1H, 13C, COSY and HMQC experiments (Table 2). The 
robustness and fidelity of this filtering strategy has been demonstrated 
at magnetic fields different to that used in the determination of R2p and 
for the sequential suppression of species in complex multicomponent 
compositions. The easy determination of R2p will facilitate the incorpo-
ration of new species in Table 1, paving the way for the application of 
the PSR filter in the analysis of complex mixtures in quality control, 
natural product extracts, or the metabolic profiling of biological sam-
ples like urine and blood plasma. 
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